NA
WX

Newport Asia’s WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS WX Stock Holding History

Newport Asia’s Portfolio WX Stock Details WX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q4 		– Sell
-714,600
Closed -$30.9M – 8
2015
Q3 		$30.9M Hold
714,600
– – 12.95% 4
2015
Q2 		$30.3M Buy
+714,600
New +$30.1M 10.52% 4

Other funds holding WX

Ninety One (UK)
Ninety One (UK) London, United Kingdom $44.7B AUM 17.24% 1-Year Est. Return
CCS
Crosspoint Capital Strategies Orinda, California $50.4M AUM 15.37% 1-Year Est. Return

Newport Asia's WX Position: Q4 2015 in Review

Newport Asia sold out of WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS (WX) in Q4 2015, closing a stake of 714,600 shares — an estimated $30.9M sold.

Newport Asia first reported a position in WX in Q2 2015 and held it in 2 quarters. The position peaked at $30.9M in Q3 2015. 2 funds tracked by Wall St. Rank hold WX as of Q4 2015.

  • Newport Asia reported no remaining WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS position as of Q4 2015 after selling out during the quarter.
  • Newport Asia sold 714,600 WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS shares in Q4 2015, an estimated $30.9M.
  • Newport Asia first reported a position in WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS in Q2 2015 and held it in 2 quarters.
  • Newport Asia's WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS position peaked at $30.9M in Q3 2015.
  • 2 funds tracked by Wall St. Rank held WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS as of Q4 2015.

Based on Newport Asia's 13F filing for Q4 2015, filed 26 Jan 2016.